How Does Mucus Clearance Differ Between Healthy Lungs And Those Affected By Cystic Fibrosis?
Question
How does mucus clearance differ between healthy lungs and those affected by Cystic Fibrosis?
Answer
As this course is geared towards respiratory therapists, the respiratory system is one of the leading systems affected by CF. Mucus is essential in the lungs, where it traps germs and pollutants that we inhale. Cilia, tiny hairs on the outside of cells, propel mucus out of the lungs and into the throat, where it can be swallowed or coughed out.
However, in a Cystic Fibrosis lung, the mucus is thick and sticky. And therefore, it is very hard for cilia to sweep up the germs and particles from the lungs. As a result, the mucus clogs the airways making it difficult to breathe. Because the mucus in people with CF is also abnormal in other ways, it is less effective at killing germs than the mucus in healthy individuals, thus creating a fertile breeding ground for lung infections, inflammation, and damage. Other symptoms of CF in the respiratory system include hemoptysis, pneumothorax, clubbing of digits, hypoxia, mucus plugging, and bronchiectasis.
This Ask the Expert is an edited excerpt from Prigi Varghese, MSN, APRN, CPNP-PC.

Prigi Varghese
MSN, APRN, CPNP-PC
Related Courses
Neuromuscular Disease Review/ Management, in partnership with Midwestern State University
This course reviews neuromuscular diseases and associated treatment strategies within the scope of Respiratory Therapy. In addition, this course also discusses the importance of an interdisciplinary approach to caring for neuromuscular patients.Tobacco Management and Smoking Cessation
This course provides a review of the various types of tobacco products and nicotine delivery devices. Additional topics include tobacco cessation and tobacco management strategies for the healthcare provider.Revisiting Adverse Childhood Experiences: Is This the Key to Managing COPD
A landmark study conducted by Kaiser-Permanente established a solid relationship between adverse childhood experiences (ACEs) and the development of Chronic Obstructive Pulmonary Disease (COPD). This interactive lecture will provide an overview of the findings from this study as well as current literature associated with the topic. An advanced discussion will challenge those providers in post-acute settings to evaluate opportunities to break the cycle of disease and improve quality-of-life for our at-risk population through education and empowerment.